Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

4.1K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.1K
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

24
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
24
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

377
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
377

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between subjective symptoms and severity in patients with Fuchs endothelial corneal dystrophy.

Japanese journal of ophthalmology·2026
Same author

Posture-Induced Intraocular Pressure Changes at Different Times of Day in Primary Open-Angle Glaucoma: Associated Factors and Exploratory Analyses of Antiglaucoma Medication Regimens.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

Decellularized Descemet Membrane Anterior Keratoplasty as a Basement Membrane Scaffold for Ocular Surface Reconstruction: Two Cases of Limbal Stem Cell Deficiency.

Cornea·2026
Same author

Breeding and characterization of a new sweetpotato cultivar, 'Miyaakari', with bright yellow flesh for confectionery processing.

Breeding science·2026
Same author

Sustained Complete Remission after Radiofrequency Ablation for Liver Oligometastasis from Pancreatic Cancer despite Persistent Carbohydrate Antigen 19-9 Elevation: A Case Report.

Surgical case reports·2026
Same author

Intrastromal misplacement of a foldable IOL during phacoemulsification: Intraoperative OCT identification of type-1 dua's layer separation.

American journal of ophthalmology case reports·2026

Related Experiment Video

Updated: Apr 21, 2026

Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.3K

Liver failure after hepatocellular carcinoma surgery.

Hiroaki Motoyama1, Akira Kobayashi, Takahide Yokoyama

  • 1First Department of Surgery, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.

Langenbeck'S Archives of Surgery
|October 23, 2014
PubMed
Summary

This study developed a new model to predict posthepatectomy liver failure (PHLF) in liver cancer patients. The model accurately identifies patients at risk, improving surgical outcomes for hepatocellular carcinoma (HCC).

More Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.7K
Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach
13:57

Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach

Published on: May 23, 2025

1.9K

Related Experiment Videos

Last Updated: Apr 21, 2026

Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.3K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.7K
Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach
13:57

Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach

Published on: May 23, 2025

1.9K

Area of Science:

  • Hepatobiliary surgery
  • Surgical oncology
  • Liver disease prediction

Background:

  • Posthepatectomy liver failure (PHLF) is a significant complication after liver surgery.
  • Accurate prediction of PHLF is crucial for managing patients with hepatocellular carcinoma (HCC) and underlying liver disease.

Purpose of the Study:

  • To develop and validate a predictive model for PHLF in HCC patients undergoing hepatectomy.
  • To assess the model's accuracy using established statistical measures.

Main Methods:

  • Retrospective analysis of 277 hepatectomies for HCC.
  • Development of a predictive model using multivariate logistic regression.
  • Internal validation through k-fold cross-validation and assessment of sensitivity, specificity, and AUROC.

Main Results:

  • PHLF occurred in 12.6% of patients.
  • Key predictors identified: elevated preoperative bilirubin, elevated international normalized ratio, and intraoperative packed red blood cell transfusion.
  • The model demonstrated good predictive performance (AUROC=0.81) and outperformed the MELD score.

Conclusions:

  • A novel predictive model for PHLF in HCC patients with liver disease has been developed.
  • The model shows potential utility in clinical practice for risk stratification and surgical planning.